Funding rounds/Verve Therapeutics

Verve Therapeutics

Series A

Cambridge, United StatesFounded 2018Jun 2020

Amount raised

€56M

€56,000,000

Native amount

56,000,000 EUR

Stage

Series A

series a

Investors

Provenance & confidence

High confidence

Amount

Reported in EUR — no conversion. €56M

High confidence

Source

High confidence

Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.

Date

Jun 2020

Round type

series a

Amount (EUR)

€56M

same company

This is the company's only recorded round.